Home›Search›Rossijskij Bioterapevticeskij Zurnal

Rossijskij Bioterapevticeskij Zurnal

ABV-press Publishing House · Russian Federation · Est. 2015

ISSN1726-9792

SJR Q4✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.12

H-Indexi

SNIPi

0.141

Total Worksi

479

Total Citationsi

711

2yr Mean Citednessi

0.19

Open Impact Factor alternative

Aims & Scope

Subject areas: Applied Microbiology and Biotechnology; Cancer Research; Immunology; Oncology.

General Information

Country / RegionRussian Federation

Primary Language—

1st Year Published2015

Annual Volume~ 37 articles / year

StatusActive (last: 2025)

Total Publications479

Publisher OrgRussian Cancer Research Center NN Blokhin

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/11 · 36%

✅

Do you know the journal / publisher?

ABV-press Publishing House

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

1726-9792

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Applied Microbiology and BiotechnologyQ4

Cancer ResearchQ4

ImmunologyQ4

OncologyQ4

Subject Classification

Scopus Categories

ImmunologyCancer ResearchApplied Microbiology and BiotechnologyOncology

Research Topics (OpenAlex)

Immunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersCancer Cells and MetastasisMonoclonal and Polyclonal Antibodies ResearchChemical Reactions and IsotopesCancer Research and TreatmentsSynthesis and biological activityRNA Interference and Gene DeliveryCancer therapeutics and mechanismsPharmacological Effects of Natural Compounds

Frequently asked questions about Rossijskij Bioterapevticeskij Zurnal

Is Rossijskij Bioterapevticeskij Zurnal a predatory journal?

PubScope has no integrity flags on record for Rossijskij Bioterapevticeskij Zurnal: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Rossijskij Bioterapevticeskij Zurnal?

Rossijskij Bioterapevticeskij Zurnal is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.12.

Is Rossijskij Bioterapevticeskij Zurnal indexed in Scopus and Web of Science?

Rossijskij Bioterapevticeskij Zurnal is indexed in Scopus.

What is the aims and scope of Rossijskij Bioterapevticeskij Zurnal?